info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Lacrimal gland and duct

CD2_BENIGN_LACRIMAL_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D31.5&
  • Hospital discharge: ICD-9 2247
  • Cause of death: ICD-10 D31.5&
  • Cause of death: ICD-9 2247

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D31
Name in latin
Neoplasma benignum glandulae lacrimalis

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 41 31 10
Unadjusted period prevalence (%) 0.01 0.01 0.00
Median age at first event (years) 63.06 61.60 67.61

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
12
5
32.84
9.55
1.3
1.2
—
—
—
0
0
22
105
3.36
3.54
3.4
5.1
—
—
—
0
0
21
109
2.90
2.77
2.1
1.4
—
—
—
0
0
8
22
4.25
2.52
1.1
1.3
—
—
—
0
0
17
83
2.79
2.46
2.2
2.2
353.2
343.2
umol/l
0.25
12
74
5
8
6.92
2.44
1.4
1.4
12.2
10.7
mg/l
—
5
8
14
62
2.91
2.41
1.3
1.4
11.3
44.7
iu/ml
—
5
22
8
26
3.56
2.15
2.3
2.5
—
—
—
0
0
5
13
4.22
1.77
1.0
1.5
—
—
—
0
0
5
13
4.22
1.77
3.6
3.1
—
—
—
0
0
7
25
3.16
1.74
2.7
1.1
—
—
—
0
0
5
16
3.41
1.48
1.4
1.1
—
—
—
0
0
5
17
3.20
1.40
1.2
1.1
—
—
—
0
0
23
157
2.06
1.40
4.9
5.4
55.8
57.0
%
0.21
17
147
17
105
2.06
1.34
2.5
2.1
2.3
2.4
mmol/l
—
8
86
17
106
2.03
1.30
4.2
3.8
—
—
—
0
0
5
21
2.57
1.12
2.4
1.9
—
—
—
0
0
19
129
1.88
1.11
2.3
4.0
5.7
132.5
e6/l
—
8
86
20
139
1.86
1.08
8.3
9.1
0.0
0.0
e9/l
0.00
15
113
30
238
1.97
1.06
4.8
4.4
—
—
—
0
0
7
35
2.20
1.06
1.0
1.5
—
—
—
0
0
22
161
1.79
0.98
5.3
5.6
28.3
28.4
%
0.01
17
148
15
98
1.84
0.96
2.5
3.2
0.1
0.6
e6/l
—
8
71
16
107
1.81
0.95
2.3
3.4
16.5
660.8
e6/l
—
8
77
6
29
2.25
0.94
1.0
1.4
—
—
—
0
0
36
312
2.26
0.93
13.0
13.5
39.7
40.1
%
0.09
23
229
25
192
1.77
0.93
6.3
5.9
4.3
4.2
e9/l
0.05
19
163
21
155
1.73
0.88
5.2
5.6
4.6
2.9
%
1.42
15
146
21
156
1.71
0.86
5.4
5.8
8.4
8.1
%
0.18
16
147
20
148
1.69
0.82
5.5
5.6
0.8
0.7
%
1.02
15
137
20
149
1.67
0.79
2.2
1.8
100.7
94.1
pmol/l
—
9
68
22
171
1.62
0.72
5.1
5.6
0.2
0.2
e9/l
0.66
17
154
7
44
1.71
0.69
1.0
1.6
—
—
—
0
0
18
136
1.58
0.64
2.4
2.9
—
—
—
0
0
5
30
1.76
0.63
1.6
2.0
—
—
—
0
0
6
35
1.83
0.61
1.2
1.5
—
—
—
0
0
0
23
0.00
0.60
0.0
6.1
—
—
—
0
0
6
36
1.78
0.60
4.5
3.7
—
—
—
0
0
6
36
1.78
0.60
1.3
1.5
—
—
—
0
0
11
75
1.64
0.58
3.6
3.2
—
—
—
0
0
13
93
1.58
0.57
2.5
3.1
—
—
—
0
0
21
168
1.51
0.57
5.2
5.1
0.0
0.0
e9/l
0.18
15
148
21
169
1.50
0.55
5.2
5.1
0.5
0.6
e9/l
0.59
15
148
36
327
1.83
0.52
6.0
5.2
1.9
1.9
mu/l
0.06
31
298
20
239
0.68
0.50
4.3
3.9
—
—
—
0
0
14
105
1.51
0.50
5.0
4.2
7.1
9.1
mg/mmol
—
7
71
13
98
1.48
0.44
3.3
3.5
24.1
52.3
mg/l
—
8
65
5
33
1.58
0.43
1.4
1.6
—
—
—
0
0
11
81
1.49
0.41
1.4
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
4.8
—
24.8
—
0
17
12
91
1.45
0.39
4.9
4.8
—
—
—
0
0
6
41
1.54
0.38
1.2
20.7
—
1.1
—
0
6
12
92
1.43
0.37
4.5
3.3
—
—
—
0
0
12
92
1.43
0.37
1.8
2.0
—
—
—
0
0
32
338
0.76
0.28
6.8
6.1
38.5
41.0
mmol/mol
0.81
27
314
5
37
1.40
0.24
1.2
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
326.5
—
0
11
0
11
0.00
0.21
0.0
1.3
—
13.5
—
0
11
0
11
0.00
0.21
0.0
1.0
—
1.1
—
0
11
0
10
0.00
0.21
0.0
2.5
—
8.5
—
0
10
0
10
0.00
0.21
0.0
2.5
—
4.9
—
0
10
0
10
0.00
0.21
0.0
5.4
—
1.3
—
0
10
0
10
0.00
0.21
0.0
2.7
—
7.4
—
0
10
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
3.9
—
—
—
0
0
7
84
0.80
0.16
2.0
3.2
—
—
—
0
0
14
123
1.21
0.15
2.2
7.6
1.0
1.2
inr
—
5
34
5
46
1.10
0.10
1.0
1.2
—
—
—
0
0
5
47
1.07
0.10
1.0
2.0
28.8
29.2
s
—
5
47
35
356
0.89
0.09
5.3
5.4
2.8
2.7
mmol/l
0.15
29
325
34
345
0.92
0.08
4.9
4.7
1.5
1.5
mmol/l
0.18
28
318
34
343
0.95
0.08
5.4
4.7
5.7
6.0
mmol/l
1.02
29
312
10
111
0.87
0.07
2.4
3.1
—
—
—
0
0
12
116
1.05
0.00
3.9
3.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
3.1
—
50.2
—
0
7
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
4.4
—
9.4
—
0
7
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
0
7
0.00
0.00
0.0
4.4
—
104.0
—
0
7
0
6
0.00
0.00
0.0
1.2
—
55.0
—
0
6
0
5
0.00
0.00
0.0
1.2
—
242.0
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
268.0
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
42.4
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
33
331
0.98
0.00
4.2
4.2
1.4
1.3
mmol/l
0.23
28
303
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
70
1.00
0.00
2.7
4.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: CD2_BENIGN_LACRIMAL_EXALLC – Benign neoplasm: Lacrimal gland and duct

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).